Immune System Drugs Flashcards
Alkylating agents prototype
Cyclophosphamide
alkylating agents therapeutic use
lymphoma, leukemia, ovarian and breast cancers
alkylating agents administration
PO and IV
alkylating agents EPA
contains Alkyl group in chemical structure > abnormal link between DNA bases, cell cycle non-specific = can kill the cell at any time in the cell cycle
alkylating agents ADRs
alopecia, bone marrow suppression, N/V, kidney damage, hemorrhagic cystitis, electrolyte imbalances
alkylating agents RN intervention and client education
monitor I&Os
Pre medicate: anti emetics, fluids to help kidneys
Immunosuppression precautions including NO live vaccines
alkylating agents contraindications and interactions
pregnancy and lactating, kidney impairment
anthracyclines prototype
Doxorubicin
anthracyclines therapeutic use
many cancer and in combination with radiation
anthracyclines administration
IV
anthracyclines EPA
binds with DNA to distort it and kill the cell. Binds to enzyme topoisomerase II to prevent repairing of DN, also killing cell = kill cancer cells and reduce metastasis
anthracyclines ADRs
alopecia, cardiac toxicity, red urine and tears, liver and kidney damage
anthracyclines RN intervention and client education
Central line!
Cardiac toxicity can occur immediately or months to years later: monitor heart rhythm and function
Monitor for thrush, super infections
Monitor s/sx liver damage, monitor CBC
anthracyclines contraindications and interactions
Avoid barbituates (dec effect of drug)
Avoid drugs that prolong QT (inc risk of cardiac effects)
pregnancy/lactation
monoclonal antibodies prototype
Trastuzumab
monoclonal antibodies therapeutic use
breast cancer (growth factor HER2+)